STUART, FL – October 13, 2017The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), parent of iRemedySupply.com and the industry transformative iRemedy ecommerce platform, today announced that SilvrSTAT® is now available through iRemedySupply.com and iRemedy’s growing national network of independent sales representatives.

SilvrSTAT Antibacterial Wound Dressing Gel from ABL Medical is a multivalent catalytic nanoparticulate molecular silver technology. It provides a new generation of wound care and in laboratory tests has been shown to inhibit the growth of microorganisms, bacteria, antibiotic-resistant strains as well as fungi. A water-based topical gel, SilvrSTAT is indicated for management of select burns, ulcers, skin tears and donor, graft, insertion and incision sites. It provides superior wound management without any known or suspected adverse reactions.

SilvrSTAT is FDA cleared as a 510(k) medical device and can be stored for three years at room temperature. To review an informative white paper on SilvrSTAT, click here.

About The iRemedy Healthcare Companies
iRemedy owns and operates iRemedySupply.com, fast emerging as America’s preferred healthcare ecommerce marketplace where healthcare consumers come to buy medical supplies, drugs, devices and technologies. Since its market launch in December 2015, thousands of consumers, physicians, nurses, dentists and enterprise users of iRemedy’s Software as a Service (“SaaS”) healthcare ecommerce solutions have joined the fast growing iRemedy community. Built from the ground-up by proven healthcare technology experts, the iRemedy platform brings modern ecommerce-driven, cost-reducing solutions to healthcare by delivering the quality, security and end-to-end supply chain management required by the industry, elegantly combining on-line requisitioning, ordering and purchasing with robust back-end inventory management and fulfillment services. iRemedy further enhances its electronic marketplace value proposition with fully integrated, SaaS-enabled tools available to iRemedy’s professional users, including managed supply chain solutions, turnkey remote patient monitoring, drug sample program and product recommendation capabilities. For more information, please visit www.iremedy.com.

COMPANY CONTACTS:

Keisha Graham
Director of Marketing
407-395-4283 | keisha@iremedy.com
Dodi Handy
VP, Investor Relations
407-960-4636 | dodi@iremedy.com
Comments are closed.